Unsaturated nitrogen-rich polymer poly(l-histidine) gated reversibly switchable mesoporous silica nanoparticles using "graft to" strategy for drug controlled release
- PMID: 28873341
- DOI: 10.1016/j.actbio.2017.08.050
Unsaturated nitrogen-rich polymer poly(l-histidine) gated reversibly switchable mesoporous silica nanoparticles using "graft to" strategy for drug controlled release
Abstract
A novel and intelligent pH-controlled system having an "on-off" switch based on poly(l-histidine) (PLH) and poly(ethylene glycol) (PEG) coated mesoporous silica nanoparticles (MSNs) (MSNs-PLH-PEG) was designed and evaluated for tumor specific drug release. The unsaturated nitrogen-rich polymer, PLH, which can change its solubility at different pH values, was employed for establishing the reversible "on-off" switch. In vitro drug release results demonstrated that MSNs-PLH-PEG has a pH-controlled "on-off" profile with the change of pH value between pH 7.4 and 5.0. Furthermore, in vitro cellular uptake study results showed that the entrapped drug could be efficiently released from MSNs-PLH-PEG under acidic endosome/lysosome. In vitro cell cytotoxicity and in vivo antitumor studies results indicated that sorafenib loaded MSNs-PLH-PEG exhibited good anti-proliferation and tumor growth inhibition effects. Haemolysis assay and histological analysis of MSNs-PLH-PEG showed negligible haemolysis activity and no visible tissue toxicity at the test dose. This study represents a promising and intelligent pH-controlled intelligent system for drug delivery and controlled release.
Statement of significance: A novel pH-controlled intelligent and reversible "on-off" switch system based on poly(l-histidine) and poly(ethylene glycol) coated mesoporous silica nanoparticles (MSNs-PLH-PEG) by "graft to" synthesis method was constructed for tumor specific drug release. The unsaturated nitrogen-rich pH-sensitive polymer, PLH, which can change its solubility in different pH values, was employed as the reversible "on-off" switch in MSNs for the first time. The pH-controlled "on-off" switch manner was observed in the drug release results in vitro. In the in vivo antitumor studies, sorafenib loaded MSNs-PLH-PEG could effectively suppressed tumor growth in H22 tumor bearing mice. It is expected that the pH-controlled intelligent "on-off" switch system we designed holds remarkable promise and provides valuable strategy for possible applications in cancer therapy.
Keywords: Graft strategy; Graft to; Mesoporous silica nanoparticles; Poly(l-histidine); Sorafenib; “On-off” switch.
Copyright © 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Amphiphilic hyperbranched polyester coated rod mesoporous silica nanoparticles for pH-responsive doxorubicin delivery.Daru. 2020 Jun;28(1):171-180. doi: 10.1007/s40199-020-00328-x. Epub 2020 Jan 31. Daru. 2020. PMID: 32006342 Free PMC article.
-
Multifunctional pH-sensitive polymeric nanoparticles for theranostics evaluated experimentally in cancer.Nanoscale. 2014 Mar 21;6(6):3231-42. doi: 10.1039/c3nr05647c. Epub 2014 Feb 6. Nanoscale. 2014. PMID: 24500240
-
Enhanced delivery of anti-inflammatory therapeutics using pH-responsive histidine-modified poly-L-lysine on mesoporous silica nanoparticles.Narra J. 2025 Apr;5(1):e1815. doi: 10.52225/narra.v5i1.1815. Epub 2025 Jan 20. Narra J. 2025. PMID: 40352234 Free PMC article.
-
Development of mesoporous silica-based nanoparticles with controlled release capability for cancer therapy.Adv Drug Deliv Rev. 2015 Dec 1;95:40-9. doi: 10.1016/j.addr.2015.09.009. Epub 2015 Oct 3. Adv Drug Deliv Rev. 2015. PMID: 26434537 Free PMC article. Review.
-
Mesoporous Silica Nanoparticles-Based Nanoplatforms: Basic Construction, Current State, and Emerging Applications in Anticancer Therapeutics.Adv Healthc Mater. 2023 Jun;12(16):e2201884. doi: 10.1002/adhm.202201884. Epub 2023 Jan 8. Adv Healthc Mater. 2023. PMID: 36529877 Review.
Cited by
-
CD13-Mediated Pegylated Carboxymethyl Chitosan-Capped Mesoporous Silica Nanoparticles for Enhancing the Therapeutic Efficacy of Hepatocellular Carcinoma.Pharmaceutics. 2023 Jan 28;15(2):426. doi: 10.3390/pharmaceutics15020426. Pharmaceutics. 2023. PMID: 36839748 Free PMC article.
-
Amphiphilic small molecular mates match hydrophobic drugs to form nanoassemblies based on drug-mate strategy.Asian J Pharm Sci. 2022 Jan;17(1):129-138. doi: 10.1016/j.ajps.2021.11.002. Epub 2021 Nov 30. Asian J Pharm Sci. 2022. PMID: 35261649 Free PMC article.
-
Mesoporous Silica Nanoparticles: Properties and Strategies for Enhancing Clinical Effect.Pharmaceutics. 2021 Apr 17;13(4):570. doi: 10.3390/pharmaceutics13040570. Pharmaceutics. 2021. PMID: 33920503 Free PMC article. Review.
-
Surface Modification of Mesoporous Silica Nanoparticles for Application in Targeted Delivery Systems of Antitumour Drugs.Polymers (Basel). 2024 Apr 16;16(8):1105. doi: 10.3390/polym16081105. Polymers (Basel). 2024. PMID: 38675024 Free PMC article. Review.
-
Natural Biopolymers as Smart Coating Materials of Mesoporous Silica Nanoparticles for Drug Delivery.Pharmaceutics. 2023 Jan 29;15(2):447. doi: 10.3390/pharmaceutics15020447. Pharmaceutics. 2023. PMID: 36839771 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials